Clinical Education InitiativeMenu
Home > Courses > Diagnosing and Managing Diabetes in HIV-infected Patients

Diagnosing and Managing Diabetes in HIV-infected Patients

Diagnosing and Managing Diabetes in HIV-infected Patients
Sorry, this learning module is not available for mobile devices.
Original Presentation: 4/14/2015
Web Posting: 7/20/2015
CE Expiration: 04/14/2018
  • Anne K. Monroe, MD, MSPH
    Assistant Professor of Medicine, Division of General Internal Medicine
    The Johns Hopkins University School of Medicine, Baltimore, MD
Learning Objectives
At the completion of this educational session, participants will:
  1. Be aware of diabetes testing strategies among HIV-infected patients.
  2. Know diabetes management strategies, including lifestyle changes and medications, for use in HIV clinical care.
  3. Understand therapeutic options, including recently released agents from new classes, for diabetes treatment.
  4. Know treatment goals and cardiovascular disease risk reduction strategies for diabetic patients.
Presenter Bio
Anne Monroe, MD, MSPH
Anne Monroe is an Assistant Professor in the Division of General Internal Medicine at the Johns Hopkins University School of Medicine. She completed medical school at SUNY Stony Brook, Internal Medicine residency and a Master of Science in Public Health degree at Jackson Memorial Hospital/University of Miami, and General Internal Medicine fellowship at Johns Hopkins. Her emphasis during fellowship training was HIV clinical care and HIV outcomes research. Since joining the faculty at Johns Hopkins, she has received a career development grant from the NIH to study how mental health and substance use disorders affect retention in HIV care and how to address these problems to improve retention. Her other research interests include metabolic and cardiovascular complications of HIV infection. She provides clinical care to a panel of HIV-infected patients at the Johns Hopkins Moore Clinic and precepts Internal Medicine residents at the Internal Medicine Residency Ambulatory Practice.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on April 14, 2015 and will terminate April, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Monroe (Presenter) had no relevant financial relationships to disclose. Dr. Monroe submitted her slides in advance for adequate peer review and will support her presentation and clinical recommendations with the best available evidence from the medical literature. 

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules